B-type natriuretic peptide (BNP) antibody and antigen (Recombinant protein)

 Download 

Product information

Size： 1mg | 10mg | 100mg

Catalog No.	Description	US $ Price (per mg)	First Order Discount	First Order Discount Price
GMP-h-BNP-Ag01	Recombinant human NPPB/BNP Protein	3090
GMP-h-BNP-Ab01	Anti-human NPPB/BNP mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-h-BNP-Ab02	Anti-human NPPB/BNP mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-h-BNP-Ab03	Anti-human NPPB/BNP human monoclonal antibody (mAb)	1953	20%	1562.4
GMP-h-BNP-Ab04	Anti-human NPPB/BNP human monoclonal antibody (mAb)	1953	20%	1562.4

Shipping Costs: $360–$760
Antibodies: $360 Antigens: $760 (Elevated cost due to antigen heterogeneity, post-translational modifications, structural complexity, and specialized handling.)

Product Description

Cat No. of Products	GMP-h-BNP-Ag01
Product Name	Recombinant human NPPB/BNP Protein
Target/Biomarker	B-type natriuretic peptide (BNP)
Alias of Target/Biomarker	BNP, Iso-ANP
Expression platform	mammalian
Isotypes	Recombinant Antigen
Bioactivity validation	B-type natriuretic peptide (BNP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in BNP level test of Cardiovascular disease (Cardiovascular Disease) and related syndrome evaluation.
Tag	His
Products description	Recombinant human NPPB/BNP Protein was synthesized.
Purity	Purity: ≥95% (SDS-PAGE)
Application	positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-h-BNP-Ab01, GMP-h-BNP-Ab02
Product Name	Anti-human NPPB/BNP mouse monoclonal antibody (mAb)
Target/Biomarker	B-type natriuretic peptide (BNP)
Alias of Target/Biomarker	BNP, Iso-ANP
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	B-type natriuretic peptide (BNP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in BNP level test of Cardiovascular disease (Cardiovascular Disease) and related syndrome evaluation.
Tag	mFc
Products description	Anti-human NPPB/BNP mouse monoclonal antibody (mAb) was synthesized.
Purity	Purity: ≥95% (SDS-PAGE)
Application	ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-h-BNP-Ab03, GMP-h-BNP-Ab04
Product Name	Anti-human NPPB/BNP human monoclonal antibody (mAb)
Target/Biomarker	B-type natriuretic peptide (BNP)
Alias of Target/Biomarker	BNP, Iso-ANP
Expression platform	CHO
Isotypes	Human lgG1
Bioactivity validation	B-type natriuretic peptide (BNP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in BNP level test of Cardiovascular disease (Cardiovascular Disease) and related syndrome evaluation.
Tag	hFc
Products description	Anti-human NPPB/BNP human monoclonal antibody (mAb) was synthesized.
Purity	Purity: ≥95% (SDS-PAGE)
Application	ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

BNP) in response to increased mechanical load and wall stretch. BNP protects the heart from adverse consequences of overload by increasing natriuresis and diuresis, relaxing vascular smooth muscle, inhibiting the renin-angiotensin-aldosterone system, and by counteracting cardiac hypertrophy and fibrosis. BNP is synthesized by cardiac myocytes as a 108-amino acid prohormone (proBNP), which is cleaved to the 32-residue BNP and the 76-residue N-terminal fragment of proBNP (NT-proBNP). Both can be used as sensitive biomarkers of cardiac dysfunction and well-characterized commercial assays have recently become available. In acute coronary syndromes increased concentrations are strong predictors of recurring myocardial infarction, heart failure, and death. In acute dyspnea, high BNP and NT-proBNP point to a cardiac rather than a pulmonary origin of the symptoms. BNP and NT-proBNP help in the assessment of the severity of ventricular dysfunction and heart failure and as a prognostic predictor, regardless of the primary cause of the condition.

About GDU